{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-17T12:21:39.588668+00:00",
  "news": [
    {
      "title": "US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5\" target=\"_blank\">US judge overturns Amgen's $50.3 mln loss in cancer drug patent case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-14T19:28:47+00:00",
      "source": "Reuters"
    },
    {
      "title": "Can Amgen Inc. continue delivering strong returns - Market Sentiment Report & Free Community Consensus Stock Picks - thegnnews.com",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOUnlsU3Z3ZjF3aElJTHhnWGhLWDZaRU9vSEZkNVE4X19takgxRDVwTTNtTG5Vbm84WU4yUWhQTkV1TS04bFdKQ3FDa1d1dG9KVXNNR0dnZEJsajJUbkVCbVR1dG1lTGFzTjRxa3p3dkYtSDRoTHlwZkgzM2ZFTGkyNDUxNFg3OHgydVpxc0RR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOUnlsU3Z3ZjF3aElJTHhnWGhLWDZaRU9vSEZkNVE4X19takgxRDVwTTNtTG5Vbm84WU4yUWhQTkV1TS04bFdKQ3FDa1d1dG9KVXNNR0dnZEJsajJUbkVCbVR1dG1lTGFzTjRxa3p3dkYtSDRoTHlwZkgzM2ZFTGkyNDUxNFg3OHgydVpxc0RR?oc=5\" target=\"_blank\">Can Amgen Inc. continue delivering strong returns - Market Sentiment Report & Free Community Consensus Stock Picks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">thegnnews.com</font>",
      "published": "2025-08-17T05:48:57+00:00",
      "source": "thegnnews.com"
    },
    {
      "title": "Ethic Inc. Has $11.75 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVFdCZmdIZWYtRzJYZGVvNVlLZ3lfU2UtbWFEYWhFeDlnOVdjQm1aQkFKY3dUNmNFQjZaRDdfMnRYcWI1V0YxX0w0T2Z1X2wyQW9PcHhKQ2d2N3pZMUVQQ09GZmVfemR5UDEzY01IVHVzN1dsRVFYQlR3TktHLWRrTnY1OWtZSlg3RzU3UFROUktKYzRjdlRFcnBMZWhXNm1FSTNtS0JUcnF5OVd5YVNldEdkVjJmbmlW?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVFdCZmdIZWYtRzJYZGVvNVlLZ3lfU2UtbWFEYWhFeDlnOVdjQm1aQkFKY3dUNmNFQjZaRDdfMnRYcWI1V0YxX0w0T2Z1X2wyQW9PcHhKQ2d2N3pZMUVQQ09GZmVfemR5UDEzY01IVHVzN1dsRVFYQlR3TktHLWRrTnY1OWtZSlg3RzU3UFROUktKYzRjdlRFcnBMZWhXNm1FSTNtS0JUcnF5OVd5YVNldEdkVjJmbmlW?oc=5\" target=\"_blank\">Ethic Inc. Has $11.75 Million Stake in Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-17T11:23:13+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5\" target=\"_blank\">Generative AI Tools Support Amgen’s Mission to Serve Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-08-07T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5\" target=\"_blank\">Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-15T14:13:20+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQZGhXSUMyUVFXVGRHZFZJaWRGTU1yME11WUZTX2VtWEZ3UzZuYVFFak12ZmN6Ukl4WTc5QXUwMm9wSjU4VDgtdkR5aUtncEdLZmxZRENmVE5oSDFkOVpuNFZNeGR2cjBjaUlWUERDbXF4Mm1mOURJZ09jS0pVUWgxYVdzeVp6dFd2NVZHUGtJaHg5aFlONHRMM1dPVzYtVTJWT09neDRUSm4xNkVLaEpxTjNJdFdBN05ZMXpLVndBVUNtcVA5b3FSS3BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxQZGhXSUMyUVFXVGRHZFZJaWRGTU1yME11WUZTX2VtWEZ3UzZuYVFFak12ZmN6Ukl4WTc5QXUwMm9wSjU4VDgtdkR5aUtncEdLZmxZRENmVE5oSDFkOVpuNFZNeGR2cjBjaUlWUERDbXF4Mm1mOURJZ09jS0pVUWgxYVdzeVp6dFd2NVZHUGtJaHg5aFlONHRMM1dPVzYtVTJWT09neDRUSm4xNkVLaEpxTjNJdFdBN05ZMXpLVndBVUNtcVA5b3FSS3BR?oc=5\" target=\"_blank\">Precision Trading with Amgen Inc. (AMGN) Risk Zones</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">news.stocktradersdaily.com</font>",
      "published": "2025-08-17T01:40:02+00:00",
      "source": "news.stocktradersdaily.com"
    },
    {
      "title": "Aberdeen Group plc Sells 126,680 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNcmZOc05GZWRyVDYxUnRQX1JQZTFSVzI1WDNMUFBJWVVQTHI3SkpGZVdRQlFHQlhZaVlnTnRzQ1ZMajFaUzVOaEwtdjhhSGxrMDZTTm4yYkhma1VyME1KY0NyZWVZSGJ4SC1wNE5EODhxM0pLd0dZN1loOG1wS3RKVEg3TFBTM0tjY0VJNVpoNUZmcGs0Q0VEMGxQU0dXcDV6VjZkdW9tTU54UVdydVRmdWNadnl4Z0czcnM3WTJhZXk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNcmZOc05GZWRyVDYxUnRQX1JQZTFSVzI1WDNMUFBJWVVQTHI3SkpGZVdRQlFHQlhZaVlnTnRzQ1ZMajFaUzVOaEwtdjhhSGxrMDZTTm4yYkhma1VyME1KY0NyZWVZSGJ4SC1wNE5EODhxM0pLd0dZN1loOG1wS3RKVEg3TFBTM0tjY0VJNVpoNUZmcGs0Q0VEMGxQU0dXcDV6VjZkdW9tTU54UVdydVRmdWNadnl4Z0czcnM3WTJhZXk?oc=5\" target=\"_blank\">Aberdeen Group plc Sells 126,680 Shares of Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-17T11:23:13+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Dimensional Fund Advisors LP Boosts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPSDA3M2NpRENFajg5bkc2dzhBQXVnRVc1UWFKMGRuSktJV2QzUnZkSFRRczR4OWpxZEFiMVUxeXc1Y2tRM1pjcWgydWpvSjRkQS1mZDhtSXY5MUM1WEhHQzhmSFVib01yNHRrOThad2owUFJjdmVhUm1NUW5DSXpkLUduWktBN0Znand3MUEwa2J4ZXBkT3FrUURhbDczU2tvRnpKY19OLXdEbVRHRnM2SFl3VEw2ZDk5X0Q2ejNHdVVqTEtr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxPSDA3M2NpRENFajg5bkc2dzhBQXVnRVc1UWFKMGRuSktJV2QzUnZkSFRRczR4OWpxZEFiMVUxeXc1Y2tRM1pjcWgydWpvSjRkQS1mZDhtSXY5MUM1WEhHQzhmSFVib01yNHRrOThad2owUFJjdmVhUm1NUW5DSXpkLUduWktBN0Znand3MUEwa2J4ZXBkT3FrUURhbDczU2tvRnpKY19OLXdEbVRHRnM2SFl3VEw2ZDk5X0Q2ejNHdVVqTEtr?oc=5\" target=\"_blank\">Dimensional Fund Advisors LP Boosts Stake in Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-17T11:23:13+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "UK court clears the way for Amgen and Samsung to launch biosimilars - Life Sciences Intellectual Property Review",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5\" target=\"_blank\">UK court clears the way for Amgen and Samsung to launch biosimilars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Life Sciences Intellectual Property Review</font>",
      "published": "2025-05-22T07:00:00+00:00",
      "source": "Life Sciences Intellectual Property Review"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-15",
      "close": 296.4700012207031
    },
    "history": [
      {
        "date": "2025-08-07",
        "close": 284.70001220703125
      },
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      },
      {
        "date": "2025-08-11",
        "close": 285.0899963378906
      },
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      },
      {
        "date": "2025-08-13",
        "close": 289.3299865722656
      },
      {
        "date": "2025-08-14",
        "close": 290.2900085449219
      },
      {
        "date": "2025-08-15",
        "close": 296.4700012207031
      }
    ],
    "name": "Amgen Inc."
  }
}